EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial

Huilian Duan, Ning Xu, Tong Yang, Moyan Wang, Chunlai Zhang, Jiangang Zhao, Zhenshu Li, Yongjie Chen, Jing Yan, Meilin Zhang, Wen Li, Zhongbao Yue und 3 weitere

Journal of Affective Disorders · 2025-01 · 369 · 35-42

DOI: 10.1016/j.jad.2024.09.131 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025-01. Verfasst von Huilian Duan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Science, School of Public Health, Tianjin Medical University, Tianjin, China; Key Laboratory of Prevention and Contr…. Hauptthemen laut MEDLINE: Dietary Supplements, Cognitive Dysfunction, Phosphatidylserines, Cognition. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Phosphatidylserine (PS) and α-Linolenic acid (ALA), are positively associated with cognitive function, but their combination effects and possible mechanisms remain unclear. We aimed to explore the effects on cognition and potential mechanism of the supplements. METHODS: This randomized, double-blind, placebo-controlled trial recruited 190 MCI patients in Tianjin, China, and randomly assigned in intervention group and placebo group. Each group consumed two capsules every day for 12 months. Each capsule for intervention group contains 144 mg ALA, 31.5 mg PS and 3.6 mg Ginkgo total flavonoids as main functional components, with 0.48 mg Vitamin B1 (as thiamine hydrochloride), 0.48 mg Vitamin B6 (as pyridoxine hydrochloride) and 90 μg folic acid as supplement. Capsules for placebo group were identical but contain no active ingredients. Cognitive function, serum n-3 polyunsaturated fatty acids (PUFAs) and neurotransmitters were assessed at baseline and 12 months. Linear mixed effects model and causal mediation analysis were conducted to explore the effects and potential mechanism of the intervention. RESULTS: A total of 190 participants (mean [SD] age, 67.95 [5.62] years; 70 (36.8 %) male and 120 (63.2 %) female) were randomized to the placebo group (n = 95) and intervention group (n = 95). Compared with placebo group, the intervention group had statistically significant improvements in arithmetic testing (β, 0.688; 95 % CI, 0.103-1.274), the similarity test (β, 1.070; 95 % CI, 0.472-1.667) and short-term memory (β, 0.600; 95 % CI, 0.399-0.800). Besides, the intervention group had statistically significant increases in serum ALA (β, 1.620; 95 % CI, 0.967-2.265), DHA (β, 2.797; 95 % CI, 1.075-4.532), EPA (β, 1.472; 95 % CI, 0.296-2.643), acetylcholine (β, 0.441; 95 % CI, 0.415-0.468), GABA (β, 0.009; 95 % CI, 0.001-0.016) and 5-HT (β, 0.160; 95 % CI, 0.081-0.238) compared to the placebo group. And the intervention may improve short-term memory by increasing serum ALA levels (average causal mediation effect = 0.132, 95 % CI, 0.053-0.225) with 19.7 % mediation proportion. CONCLUSIONS: This food supplement containing phosphatidylserine could improve different cognitive functions of MCI patients, especially short-term memory, and increase serum n-3 PUFAs and neurotransmitters levels. Serum ALA level might play a mediation role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsCognitive DysfunctionPhosphatidylserinesCognitionHumansMaleFemaleDouble-Blind MethodAgedChinaMiddle Agedalpha-Linolenic AcidFatty Acids, Omega-3East Asian People

Stichwörter der Autor:innen

Mild cognitive impairmentPhosphatidylserinePlacebo-controlled trialRandomized double-blindα-Linolenic acid

Substanzen

Phosphatidylserinesalpha-Linolenic AcidFatty Acids, Omega-3

Autor:innen und Institutionen

  • Department of Nutrition and Food Science, School of Public Health, Tianjin Medical University, Tianjin, China; Key Laboratory of Prevention and Control of Major Diseases in the Population, Ministry of Education, Tianjin…
  • Department of Epidemiology & Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China; Key Laboratory of Prevention and Control of Major Diseases in the Population, Ministry of Education, Tianj…
  • Community Health Service Center, Sanhuailu Street, Binhai New District, Tianjin, China.
  • Department of Social Medicine and Health Management, School of Public Health, Tianjin Medical University, Tianjin, China; Key Laboratory of Prevention and Control of Major Diseases in the Population, Ministry of Educati…
  • BYHEALTH Institute of Nutrition & Health, Guangzhou, China.
  • BYHEALTH Institute of Nutrition & Health, Guangzhou, China. Electronic address: herk@by-health.com.

Zitieren

APA

Duan, H., Xu, N., Yang, T., Wang, M., Zhang, C., Zhao, J., Li, Z., Chen, Y., Yan, J., Zhang, M., Li, W., Yue, Z., Ma, F., He, R., & Huang, G. (2025). Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial. Journal of Affective Disorders, 369, 35-42. https://doi.org/10.1016/j.jad.2024.09.131

Vancouver

Duan H, Xu N, Yang T, Wang M, Zhang C, Zhao J, et al. Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial. Journal of Affective Disorders. 2025;369:35-42. doi:10.1016/j.jad.2024.09.131

BibTeX
@article{Duan2025,
  author = {Duan, Huilian and Xu, Ning and Yang, Tong and Wang, Moyan and Zhang, Chunlai and Zhao, Jiangang and Li, Zhenshu and Chen, Yongjie and Yan, Jing and Zhang, Meilin and Li, Wen and Yue, Zhongbao and Ma, Fei and He, Ruikun and Huang, Guowei},
  title = {Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial},
  journal = {Journal of Affective Disorders},
  year = {2025},
  volume = {369},
  pages = {35--42},
  doi = {10.1016/j.jad.2024.09.131}
}
Kostenlos starten →